A Double-Blind, Randomised, Placebo-Controlled Study to Evaluate the Photoprotective Effect of a Sustained Release dose of Melanotan in Fair skinned Healthy Caucasians

Trial Profile

A Double-Blind, Randomised, Placebo-Controlled Study to Evaluate the Photoprotective Effect of a Sustained Release dose of Melanotan in Fair skinned Healthy Caucasians

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Jun 2016

At a glance

  • Drugs Afamelanotide (Primary)
  • Indications Sunburn
  • Focus Therapeutic Use
  • Acronyms EP008
  • Sponsors Clinuvel Pharmaceuticals
  • Most Recent Events

    • 29 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top